JAX team to study cancer immunotherapy
The Jackson Laboratory (JAX) has received $2.5 million from The Mark Foundation for Cancer Research to study in mice the influence of host genetics on...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
The Jackson Laboratory (JAX) has received $2.5 million from The Mark Foundation for Cancer Research to study in mice the influence of host genetics on...
BioXcel Therapeutics has announced announced the initiation of its SERENITY (Sub-Lingual DExmedetomidine in Agitation Associated With SchizophRENIa and Bipolar Disorder STudY) program, two Phase 3 studies of...
Melinta Therapeutics has entered into a restructuring support agreement with the lenders pursuant to a pre-negotiated chapter 11 plan of reorganization. “We are confident that...
Alexion Pharmaceuticals and Dicerna™ Pharmaceuticals have announced that Alexion has exercised its option for exclusive rights to two additional targets within the complement pathway for...
More than one in 10 Americans suffer from migraine headaches, and the vast majority of patients report that the pain prevents them from working. Biohaven...
A new drug to treat bladder and urinary tract cancers, developed by Yale Cancer Center and Smilow Cancer Hospital researchers, has been approved by the...
Rebecca Campbell-Montalvo, postdoctoral research associate in the Neag School’s Department of Curriculum and Instruction, is co-principal investigator on a new $500,000 federal research grant funded...
A prescription drug bill that cleared the U.S. House last week seeks to curb skyrocketing drug prices charged by large pharmaceutical firms. But the price...
Shareholders of Achillion Pharmaceuticals have overwhelmingly approved the company’s takeover by fellow New Haven-born drug maker Alexion Pharmaceuticals for $930 million. Achillion said approximately 99...
Almost every course in the UConn entrepreneurship curriculum has moved away from exam-based assessment and theoretical course content, in favor of building and doing. Furthermore,...